Advertisement

Topics

Latest Orthopedics NewsRSS

10:37 EDT 20th September 2017 | BioPortfolio

Alpine Immune Sciences Announces Poster Presentation at 2017 ACR/ARHP Annual Meeting

Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading immunotherapy company focused on developing treatments for autoimmune/inflammatory diseases and cancer, today announced a planned poster presentation highlighting recent data from a preclinical study evaluating dual ICOS/CD28 antagonists generated by the Company’s vlgD™ platform at the upcoming 2017...

Nature's Way® Launches New Turmerich™ Line of Targeted Turmeric Formulas

GREEN BAY, Wis., Sept. 20, 2017 /PRNewswire/ -- Nature's Way® Brands, LLC, one of the most recognized and trusted consumer dietary supplements brands, introduces Turmerich™, a new line of premium turmeric-based herbal products, formulated to address specific health needs. The line will initially offer two formulas: Turmerich Joint, for joint and mobility support*, and Turmerich Heart, for cardi...

Protect Your Kids This Flu Season

CINCINNATI, Dec. 5, 2011 /PRNewswire-USNewswire/ -- Doctors at Cincinnati Children's Hospital Medical Center want to make sure children are protected from influenza this flu season.  The flu is an infection of the nose, throat and lungs caused by a variety of strains of influenza viruses that circulate in communities every year. According to the web site Preventchildhoodinfluenza.org, i...

“Stem Cell Therapy: A Rising Tide - How Stem Cells are Disrupting Medicine and Transforming Lives” - A New Book by Stem Cell Expert, Dr. Neil Riordan, Is On Sale Now

Neil H Riordan, author of MSC: Clinical Evidence Leading Medicine’s Next Frontier, the definitive textbook on clinical stem cell therapy, authors an easy-to-read book about what stem cells are, what they are not, how and why stem cells work, and why they’re the wave of the future. It provides fascinating insight into the therapeutic use of mesenchymal stem cells. Dallas-Fort Worth, Texas (PRWE...

XW Labs secures over $17M Series B financing led by Elements Capital and WI Harper

WUHAN, China, Sept. 20, 2017 /PRNewswire/ -- XW Laboratories Inc. (XW Labs), a biopharmaceutical Research and Development (R&D) company focused on neurological disorders, today announced the closing of a $17.5 million Series B financing led by Elements Capital and WI Harper with participation from new investor KTB Network, and all existing investors Kleiner Perkins Caufield & Byers Ch...

Marathon Pharmaceuticals LLC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24082017] Prices from USD $250

SummaryMarathon Pharmaceuticals LLC Marathon Pharmaceuticals focuses on the development, manufacturing and commercialization of treatments for rare neurological and movement disorders. It develops products in various therapeutic areas which include duchenne muscular dystrophy, pediatric juvenile idiopathic arthritis, neuromyelitis optica, idiopathic inflammatory myopathies, catastrophic pediatric ...

Enterome to Move its Research Laboratories to Genopole, France's First Biocluster

PARIS, September 20, 2017 /PRNewswire/ -- ENTEROME SA, a pioneer of innovative therapies for microbiome-related diseases, announced today that the Company is moving its research laboratories to Genopole, a leading biocluster dedicated to biotechnology and research in genomics and genetics. The new laboratories brings Enterome closer to its existing and potential new partners and provides oppor...

Interprotein Corp Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23082017] Prices from USD $250

SummaryInterprotein Corp Interprotein is a drug discovery company that conducts research and develops small molecule drugs. The company provides IL6 inhibitor, IgE inhibitor, notch1 inhibitor, tubulin polymerization inhibitors, TIM3 inhibitor, NKG2A, HLAE and CD94 inhibitor; KIR and HLAC inhibitor; gp130 inhibitor and RUNX1 and CBF inhibitor products. Its IL6 inhibitor is used in the treatment of ...

SANUWAVE Announces Exhibition at Medica in Cooperation With State of Georgia; Visit us at Booth 16D10-8 in Hall 16

SUWANEE, GA -- (Marketwired) -- 09/20/17 -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the company will exhibit, in conjunction with Georgia Department of Economic Development, at MEDICA in Dusseldorf, Germany on 13 -16 November 2017. SANUWAVE cordially invites you to our section of booth 16D10-8 in Hall 16. MEDICA is the world's leading trade fair for the medical industry. S...

Facts about fluorosis – not a worry in New Zealand

A recent issue of the Fluoride Exposed Newsletter gives us the facts about dental fluorosis – a subject very often misrepresented by opponents of community water fluoridation. Ever notice how words ending with “-osis” sound a bit scary?  That’s because “-osis” is a suffix (from the Greek) commonly used to describe disorders or abnormal states. […] The post Facts about fluorosis ...

Tarsa Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24082017] Prices from USD $250

SummaryTarsa Therapeutics Inc Tarsa develops therapies for the treatment and prevention of osteoporosis and other bone related diseases. The company develops TBRIA, an oral formulation of calcitonin, a peptide hormone that inhibits bone resorption, which is used for the treatment of postmenopausal osteoporosis in women at least five years post menopause. The company also offers osteoporosis treatm...

FDA OKs Glaxo's inhaler, first one to combine 3 medicines

The Food and Drug Administration has approved the first inhaler combining three medicines to ease breathing in patients with emphysema or chronic bronchitis. The FDA late Monday approved sales of Trelegy Ellipta, developed jointly by GlaxoSmithKline PLC and Innoviva Inc. It contains three widely used types of medicine to prevent - rather than treat -flare-ups of the life-threatening breathing diso...

CME Outfitters Launches New Online Biosimilars Hub

CME Outfitters is excited to announce its newest online education hub featuring free CE activities and resources on the use of biosimilars in clinical practice to treat inflammatory diseases Bethesda, MD (PRWEB) September 19, 2017 CME Outfitters (CMEO), a leading accredited provider in continuing medical education, has launched a unique Biosimilars Education Hub where clinicians can find up to da...

CME Outfitters Offering Two New Snacks on the Use of Biosimilars in the Treatment of Inflammatory Diseases

Two new CME “Snacks” on using biosimilars to treat inflammatory disease are now available for free participation and CE credit from CME Outfitters Bethesda, MD (PRWEB) September 19, 2017 CME Outfitters, LLC, a leading accredited provider in continuing medical education, announces the launch of a new pair of CME Snacks (short online CME activities) discussing the newly approved biosimilar, inf...

F4CP Highlights Suffering of Addicted Babies, Cites Value of Chiropractic Care during Pregnancy to Address Spine Pain, and Supports Universal Drug Screening of Pregnant Women

F4CP supports recommendations from The American College of Obstetricians and Gynecologists (ACOG) calling for early universal screening for substance abuse as part of comprehensive obstetric care

Idiopathic Thrombocytopenic Purpura Immune Thrombocytopenic Purpura Pipeline Review, H2 2017 [Report Updated: 22082017] Prices from USD $2000

Idiopathic Thrombocytopenic Purpura Immune Thrombocytopenic Purpura Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Idiopathic Thrombocytopenic Purpura Immune Thrombocytopenic Purpura Pipeline Review, H2 2017, provides an overview of the Idiopathic Thrombocytopenic Purpura Immune Thrombocytopenic Purpura Hematological Disorders p...

National Association of Specialty Pharmacy Names Ardon Health Specialty Pharmacy of the Year & Honors Mike Agostino with the Distinguished Service Award

WASHINGTON, Sept. 19, 2017 /PRNewswire-USNewswire/ -- Kicking off the fifth annual National Association of Specialty Pharmacy (NASP) meeting today, outgoing NASP President Rebecca Shanahan announced the industry's two much-anticipated awards recognizing the best in the business of specialty pharmacy this year. Of the 1,200 corporate association members, Ardon Health was named Specialty P...

What are the critical unmet needs regarding dry eye?

PointIn my opinion, one of the critical unmet needs is a simple and effective method to diagnose inflammation. Inflammation is a key point in the diagnosis because it allows us to differentiate between different types of dry eye disease. Some forms of dry eye do not have an inflammatory component, typically the feeling of dryness, burning and ocular fatigue affecting people who watch screens for a...

Array of devices available for preoperative cataract testing

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.As our cataract surgery precision continues to improve, patient expectations continue to escalate. There are now many new technologies available to aid in our cataract testing to help optimize ou...

CEL-SCI Announces $1.5 Million NIH SBIR Grant to Support Development of Rheumatoid Arthritis Vaccine

Previous pre-clinical studies show CEL-SCI’s LEAPS technology prevented the development, lessened the severity of arthritis and described in part the mechanism of action and target cells CEL-SCI Corporation (NYSE American: CVM) announced today that it has been awarded a new Phase II Small Business Innovation Research (SBIR) grant by the National Inst...

A Major Step Forward in Orthopedics at NewYork-Presbyterian Lawrence Hospital

Announces New Orthopedic Team with Expanded Services Bronxville, NY (PRWEB) September 19, 2017 NewYork-Presbyterian Lawrence Hospital Orthopedics is undergoing an exciting transformation, ushered in by nationally renowned sports medicine and orthopedic physicians from Columbia University Medical Center (CUMC). Doctors will be seeing patients in Bronxville and Tarrytown, with surgical procedures ...

EffRx Pharmaceuticals: Binosto Data Presented at the ASBMR Congress in Denver

EffRx Pharmaceuticals SA is proud to inform that the latest safety data on Binosto® were presented as a poster on Sunday, 10th of September 2017 at the American Society for Bone and Mineral Research (ASBMR) 2017

MedQuest Signs Joint Venture Agreements with Multiple Health Systems, Emerges as Leading Outpatient Imaging Partner

In today’s healthcare environment with unprecedented pressure on providers to develop cost-effective and accessible diagnostic imaging networks, MedQuest Associates has emerged as a leading

MiMedx Files With The FDA To Initiate The Company's Investigational New Drug Phase 2 Clinical Trial For Osteoarthritis Of The Knee

MARIETTA, Ga., Sept. 19, 2017 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare, announced today that the Company has filed with the Food and Drug Administration (FDA) to initiate i...

Gov. Haslam proclaims October 10 Depression, Bipolar and Mood Disorder Awareness Day in Tennessee

NASHVILLE, Tenn., Sept. 19, 2017 /PRNewswire/ -- Gov. Bill Haslam, in support of the Depression and Bipolar Support Alliance (DBSA) of Tennessee, has proclaimed Tuesday, October 10, as Depression, Bipolar and Mood Disorder Awareness Day. The governor's proclamation coincides with the World Health Organization's World Mental Health Day and recognizes the importance of raising awareness and supp...

Quick Search
Advertisement
 

review and buy Orthopedics market research data and corporate reports here